In this event, VIVEbiotech had the opportunity to arrange relevant partnering meetings with Biotech and Pharmaceutical companies involved in the development of a Gene Therapy pipeline that involves the use of Lentiviral vectors. Moreover, relevant meetings were hold with international Companies interested in different collaborative approaches for the development of Lentisoma (non-integrative replicative episomal lentiviral vector).

Additionally, VIVEbiotech exhibited at this international event considered as the most important event for Biotech sector.

Herein, a picture of Juan Carlos and Natalia is shown.